openPR Logo
Press release

IQ4I Research & Consultancy published a new report on “Incontinence and Ostomy care Global Market – Forecast To 2023”

02-16-2017 10:28 AM CET | Health & Medicine

Press release from: IQ4I Research & Consultancy Pvt Ltd

IQ4I Research & Consultancy published a new report

Incontinence is the involuntary loss of urine or stool, this is a widespread condition and varies with severity from small leaks to complete loss of control of the bladder or bowel. The two main types of incontinence are urinary incontinence and fecal incontinence. Urinary incontinence can be further classified as stress incontinence, urge incontinence, overflow incontinence and mixed incontinence. An ostomy is a surgical process of creating an opening in the abdomen wall, called a stoma, which may be temporary or permanent. In conditions wherein a section of the bowel has to be removed as in case of colorectal cancer or in conditions when section of the bowel or urinary system requires time to heal, temporary or permanent ostomies are opted. Based on the region being surgically excised for the stoma, ostomy can be classified as ileostomy, colostomy and urostomy. The incontinence and ostomy care global market is expanding at a steady rate, as estimated by IQ4I Research, the incontinence and ostomy care global market is expected to grow at mid single digit CAGR to reach $22,150.3 million by 2023.

Growing prevalence of medical conditions such as women related conditions (for e.g. childbirth, menopause), inflammatory bowel diseases (Crohn’s disease and ulcerative colitis), neurological diseases (multiple sclerosis, Parkinson’s disease etc), oncology (colorectal and prostate cancer) and others diseases, increase in population prone to aging related medical conditions, increase in awareness and acceptance of the condition of incontinence and ostomy, and development of more personalized products for greater patient comfort and care are driving the market growth. Most disposables used in the incontinence and ostomy care market raise environmental concerns which are a factor that may hinder the growth of the market. The limited reimbursement facilities and alternative treatments that include pharmaceutical drugs, exercises, electroceuticals, laser surgeries and radiotherapies are threats for the market growth.

The Incontinence and Ostomy care global market is segmented into products, applications, end-user and by geography. The market is classified based on products into incontinence and ostomy care products. Incontinence care products segment accounted largest revenue in 2016 is project to grow at mid single digit CAGR as per estimates of IQ4I Research.

Incontinence and Ostomy care global market is classified by application into neurological conditions, oncology, urinogenital diseases, GI Tract diseases, women health related and others. Women health related segment accounted for the largest share in 2016, Oncology segment is the fastest growing segment and is projected to growth at a high CAGR as per estimates of IQ4I Research.

The End-user market consists of hospitals, private clinics and home care centers. Among them home care segment occupied largest share and is projected to maintain the status as largest segment throughout the forecast period.

The Incontinence and Ostomy global market based on geography is divided into North America, Europe, Asia-Pacific and Rest of the world. Europe region commanded the largest revenue in 2016 due to favourable reimbursement coverage and high investments in healthcare infrastructures that have led to the market growth in this region. However, Asia- Pacific region is expected to grow at the highest CAGR due to increasing healthcare awareness, higher economic growth, large patient pool and rising aged population.

Some of the prominent players in incontinence and ostomy care market include B. Braun Melsungen AG (Germany), Coloplast AG (Denmark), ConvaTec Inc. (U.S.), Hollister Inc. (U.S.), Kimberly-Clark Corporation (U.S.), Medtronic Inc. (Ireland), Salts Healthcare (U.K.), Svenska Cellulosa Aktiebolaget (Sweden), Unicharm Corporation (Japan), P & G (U.S.), Paul Hartmann (Germany) and Ontex (Belgium).

IQ4I (Intelligence Quotient for Innovation) Research and Consultancy Pvt. Ltd. is a global strategy, consulting and a leading market research company. Our clients include leading businesses, investment banks, researchers and government agencies.

We are a team of highly qualified consultants and market researchers, committed to help clients make strategic decisions by providing relevant and firmly reliable market intelligence support. We enable our clients to identify the market opportunities with best-in-class market intelligence reports.

IQ4I Research & Consultancy Pvt Ltd,
No.11, Industrial Suburb,
West of Chord Road,
Rajajinagar, Bangalore-560010

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release IQ4I Research & Consultancy published a new report on “Incontinence and Ostomy care Global Market – Forecast To 2023” here

News-ID: 439003 • Views:

More Releases from IQ4I Research & Consultancy Pvt Ltd

IQ4I Research & Consultancy published a new report on
IQ4I Research & Consultancy published a new report on "Prefilled Syringes Global …
Prefilled syringes (PFS) are the sterile primary packaging systems or sealed containers that can also function as efficient drug delivery systems for the pre-loaded desired dose of parenteral pharmaceutical product. By engineering easier usability and improved patient experience into prefilled syringes, various prefilled syringe products have gained an unrivalled position as the most preferred or attractive container of choice for delivering injectable medical products in the market and have evolved
Cell Analysis Global Market estimated to be worth $39.3 billion by 2025
Cell Analysis Global Market estimated to be worth $39.3 billion by 2025
IQ4I Research & Consultancy published a new report on “Cell Analysis Global Market-Forecast to 2025”. Techniques: • Molecular approach  PCR  Sequencing  Microfluidics and Microarrays  Cell separation and isolation techniques • Image-Based Approach  Microscopy  Cytometry  High Content Screening  Spectrophotometry Products: • Consumables • Assay Kits • Microplates • Reagents • Cell culture consumables • Others • Instruments • Cell Counters • Cell Microarrays and Microfluidics • Liquid handling systems • Cytometers • High Content Screening • Microplate readers • PCR Instruments • Sequencing instruments • Spectrophotometers • Microscopes • Others Instruments • Software and Services Application: • Process of application • Cellular processes • Circulating Tumor Cells • Signal Transduction Pathway • Subpopulation Characterization • Drug and Candidate Screening • Single-cell analysis • Epigenetic target analysis • Field of Application  Forensic  Therapeutics  Cell Imaging  Biomarker research  Genomic analysis  Stem cell analysis  Diagnostics • Therapeutic Area of Application  Cancer
IQ4I Research & Consultancy published a new report on “Electrosurgical devices Global Market – Forecast To 2025”
IQ4I Research & Consultancy published a new report on “Electrosurgical devices …
Electrosurgery procedures employ devices where electrical energy is used to achieve a desired clinical effect in which a radio-frequency (RF), alternating current at a various voltage ranging from 200-10,000V is passed through the biological tissues to cut, coagulate, desiccate, or even to fuse tissue. Its benefit includes the ability to make precise cuts with limited blood loss during surgery. In electrosurgical procedures, the tissue is heated by an alternate current.
IQ4I Research & Consultancy published a new report on “Pharmaceutical Excipients Global Market – Forecast To 2025”
IQ4I Research & Consultancy published a new report on “Pharmaceutical Excipien …
Pharmaceutical Excipients are non-active substances combined with active pharmaceutical ingredient (API) during formulation to form a desired finished drug product, which helps in modulating solubility, bioavailability, stability and perform a wide range of functions. Pharmaceutical excipients are naturally derived or manufactured through semi-synthetic or synthetic modes. They are classified based on their physio-chemical characteristics in formulating different dosage forms based on nature of active ingredient and intended route of administration.

All 5 Releases


More Releases for Incontinence

Disposable Incontinence Products Market: "Disposable Incontinence Products to Re …
Disposable Incontinence Products Market Scope: Key Insights : Disposable Incontinence Products Market size was valued at USD 12.4 billion in 2022 and is poised to grow from USD 13.33 billion in 2023 to USD 23.77 billion by 2031, growing at a CAGR of 7.50% during the forecast period (2024-2031). Access the full 2024 Market report for a comprehensive understanding @https://www.skyquestt.com/report/disposable-incontinence-products-market In-Depth Exploration of the global Disposable Incontinence Products Market: This report
Urinary Incontinence Market Key Players, Size, Share, Forecasts to 2028 and Inco …
Urinary Incontinence is a global health issue that affects around 200 million people globally. The disorder may occur at any age due to several factors however it's largely associated with the elderly population because of the high prevalence of UI in adults over age 65, who are the key end-user demographic of Urinary incontinence products. The Global Urinary Incontinence Market is expected to generate 21.1 billion by the end of
Urinary Incontinence - Drug Pipeline Landscape, 2023
Urinary incontinence (UI) is the involuntary leakage of urine. UI happens when the muscles in the bladder that control the flow of urine contract or relax involuntarily, resulting in leaks or uncontrolled urination. The common causes of urinary incontinence include overactive bladder muscles, weakened pelvic floor muscles, nerve damage, interstitial cystitis (chronic bladder inflammation), obstruction, neurological disorders such as multiple sclerosis, stroke, or Parkinson's disease. Urinary incontinence may also be
Urinary Incontinence Market: New research activities show links between urinary …
The prevalence of urinary incontinence has affected a majority of population and the possibility of this condition increases with age. Majority of old adults and women have been facing the issue and availing treatments to improve quality of lives. Research activities found the connection between urinary incontinence and other health conditions such as mental health and falls. After conducting different research activities, new findings have emerged. Researchers suggested doctors to
Urinary Incontinence Device Market Growing Prevalence of Urologic Illness and Aw …
According to Precision Business Insights (PBI), the latest report, urinary incontinence device market is expected to be worth USD 3,183.2 million in 2022, growing at a 5.8% CAGR from 2022 to 2028. The primary driver of the expansion of the Global Urinary Incontinence Device Market is the increased prevalence of urinary diseases of which urinary incontinence is associated with complications and also the development of more sophisticated and advanced incontinence
Growing Awareness about Prevalence of Urinary Incontinence Stimulating Incontine …
Worldwide consumption of incontinence bedding & furniture protection products is anticipated to rise at a CAGR of 4.9% between 2022 and 2032. At present, the global incontinence bedding & furniture protection market is valued at US$ 632 million and is anticipated to top a market valuation of US$ 1 billion by the end of 2032. Rising amount of trash produced by disposable products, their high price, and increasing preference for eco-friendly products are driving high demand for